Welcome to our dedicated page for Uipath SEC filings (Ticker: PATH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The UiPath, Inc. (NYSE: PATH) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures, giving investors and researchers a structured view of how this software publisher reports on its automation and AI business. As a public company, UiPath files documents with the U.S. Securities and Exchange Commission, including current reports on Form 8-K and other periodic filings.
Recent Form 8-K filings for UiPath include results of operations and financial condition, where the company furnishes press releases announcing quarterly financial results. These filings typically reference revenue performance, Annualized Renewal Run-rate (ARR), dollar-based net retention rate, and other operating metrics, along with management commentary on the progress of UiPath’s agentic automation strategy. Another 8-K filing details matters submitted to a vote of security holders at the annual meeting, such as director elections, advisory votes on executive compensation, and ratification of the independent registered public accounting firm.
UiPath also uses Form 8-K to disclose other material events, such as the adoption of a Rule 10b5-1 trading plan by an entity controlled by its founder and chief executive officer. That filing explains the plan’s purpose within a personal long-term investment strategy and notes that the shares subject to the plan represent a limited portion of the individual’s holdings, while the individual remains a significant controlling stockholder.
On Stock Titan, UiPath filings are updated as they appear on EDGAR, and AI-powered summaries help explain the substance of each document. Users can quickly understand the context of earnings-related 8-Ks, governance disclosures, and other material events without reading every line of the underlying filing. For more detailed analysis, investors can review the full text of each filing alongside these AI-generated overviews.
PATH shareholder BRAD C BRUBAKER filed a Rule 144 notice covering the planned sale of 27,580 common shares through Morgan Stanley Smith Barney LLC on the NYSE, with an approximate sale date of 12/05/2025 and an aggregate market value of $509,678.40. These shares were acquired as restricted stock units from the issuer on 04/01/2024.
The notice also reports that the same shareholder sold PATH common stock over the prior three months, including 27,580 shares on 10/15/2025, 66,665 shares on 10/06/2025, and 16,083 shares on 09/30/2025. The filing states that there were 453,568,899 shares of the issuer’s common stock outstanding, providing a baseline for the size of this planned sale.
UiPath, Inc. insider reports share sale under a pre-arranged plan. A reporting person who is a director, CEO, chairman and 10% owner of UiPath (PATH) sold 45,000 shares of Class A common stock on 12/05/2025 in an open-market transaction coded as a sale. The weighted average sale price was about $18.1952 per share, with individual trade prices ranging from $18.0900 to $18.3100.
Following this transaction, the insider beneficially owns 29,243,585 shares of UiPath Class A common stock in direct form. The filing states that the sale was made under a qualified Rule 10b5-1 trading plan, which is a pre-established program intended to allow insiders to sell shares according to preset instructions.
UiPath, Inc. reported that it has released its financial results for the fiscal third quarter 2026. The company announced that these results were communicated through a press release dated December 3, 2025, which is provided as an exhibit to the report. The press release contains the detailed financial and operating information for the period.
The company notes that this earnings information, including the press release, is being furnished rather than filed under securities laws, which affects how it is treated for legal liability and incorporation into other regulatory documents.
UiPath (PATH) received an amended Schedule 13G (Amendment No. 1) from co-founder Daniel Dines reporting his beneficial ownership. As of September 30, 2025, Dines beneficially owned 105,697,391 shares, equal to 19.9% of Class A on an as-converted basis and representing 86.1% of the company’s total voting power.
The stake comprises 31,631,388 shares of Class A (held via IceVulcan Investments Ltd and Ice Vulcan Holding Limited) and 74,306,003 shares of Class B (held via Ice Vulcan Holding Limited). Class B converts 1‑for‑1 into Class A and carries 35 votes per share versus one vote for Class A. As of October 13, 2025, Dines no longer has voting or dispositive power over 240,000 Class A shares previously reported.
UiPath (PATH): Insider transaction disclosed. A reporting person who serves as CEO and Chairman, and is also a director and 10% owner, sold 45,000 shares of Class A common stock on 11/05/2025. The reported transaction price was $15.0748 per share; the filing notes executions occurred between $15.00 and $15.15 under a Rule 10b5-1 trading plan. Following the sale, the reporting person directly owned 29,288,585 shares.
UiPath, Inc. (PATH) insider transaction: The CEO and Chairman, who is also a Director and 10% Owner, reported selling 45,000 shares of Class A Common Stock on 11/04/2025 under a Rule 10b5-1 trading plan. The reported execution price for the sale is $15.0243, with the filing noting a trade range from $15.0000 to $15.1200.
Following this transaction, the reporting person beneficially owns 29,333,585 shares, held directly. The filing indicates the trade was executed pursuant to a pre-established plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
UiPath (PATH) CEO and Chairman Daniel Dines reported an insider sale. On 11/03/2025, he sold 45,000 shares of Class A common stock at an average price of $16.2264, executed under a qualified Rule 10b5-1 trading plan. The reported trade price range was $16.0500 to $16.4200.
Following this transaction, Dines beneficially owned 29,378,585 shares, held directly. He is listed as Director, Officer, and 10% Owner. The filing notes full trade details are available upon request to the company or Commission staff.
UiPath (PATH) insider activity: CEO and Chairman (also a 10% owner) reported selling 45,000 shares of Class A common stock on 10/31/2025 at an average price of $15.7171. The transaction was executed pursuant to a qualified Rule 10b5-1 trading plan.
Following the sale, the reporting person beneficially owns 29,423,585 shares, held directly. The filing notes the sale prices ranged from $15.5700 to $15.8500, with full trade-by-trade details available upon request.
UiPath (PATH) insider transaction: A reporting person who is the CEO and Chairman, Director, and a 10% Owner reported selling 45,000 shares of Class A common stock on 10/30/2025 at an average price of $15.7254 under a Rule 10b5-1 trading plan. The disclosed trade occurred within a price range of $15.4500 to $16.0000. Following the sale, the filer beneficially owns 29,468,585 shares, held directly.
UiPath (PATH) CEO and Chairman, who is also a Director and 10% Owner, reported open-market sales of Class A common stock under a Rule 10b5-1 trading plan. He sold 45,000 shares on 10/27/2025 at a weighted average price of $16.726, 45,000 shares on 10/28/2025 at $17.1632, and 45,000 shares on 10/29/2025 at $16.2874.
Following these transactions, the reporting person beneficially owned 29,513,585 shares of Class A common stock. A footnote states he no longer has a reportable beneficial interest in 240,000 shares previously included in ownership reports.